Encompass Health ROE 2010-2023 | EHC

Current and historical return on equity (ROE) values for Encompass Health (EHC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Encompass Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.35B $2.26B 16.87%
2023-09-30 $0.35B $2.15B 17.83%
2023-06-30 $0.31B $2.02B 16.74%
2023-03-31 $0.27B $1.93B 13.61%
2022-12-31 $0.27B $1.83B 12.78%
2022-09-30 $0.27B $1.71B 12.16%
2022-06-30 $0.33B $2.50B 13.76%
2022-03-31 $0.39B $2.45B 17.01%
2021-12-31 $0.41B $2.36B 18.65%
2021-09-30 $0.41B $2.26B 19.22%
2021-06-30 $0.38B $2.18B 19.00%
2021-03-31 $0.31B $2.04B 15.76%
2020-12-31 $0.29B $1.97B 15.21%
2020-09-30 $0.27B $1.90B 14.80%
2020-06-30 $0.29B $1.83B 16.36%
2020-03-31 $0.34B $1.80B 20.34%
2019-12-31 $0.36B $1.69B 21.81%
2019-09-30 $0.32B $1.67B 19.79%
2019-06-30 $0.31B $1.58B 19.55%
2019-03-31 $0.31B $1.62B 19.88%
2018-12-31 $0.29B $1.56B 19.27%
2018-09-30 $0.34B $1.58B 22.97%
2018-06-30 $0.32B $1.50B 22.21%
2018-03-31 $0.29B $1.44B 20.82%
2017-12-31 $0.27B $1.40B 21.38%
2017-09-30 $0.26B $1.37B 22.68%
2017-06-30 $0.26B $1.32B 24.80%
2017-03-31 $0.26B $0.98B 28.00%
2016-12-31 $0.25B $0.93B 28.21%
2016-09-30 $0.23B $0.91B 27.33%
2016-06-30 $0.22B $0.85B 27.02%
2016-03-31 $0.20B $0.82B 25.21%
2015-12-31 $0.18B $0.78B 24.48%
2015-09-30 $0.18B $0.79B 25.01%
2015-06-30 $0.17B $0.77B 26.59%
2015-03-31 $0.21B $0.64B 35.38%
2014-12-31 $0.22B $0.62B 38.58%
2014-09-30 $0.15B $0.59B 28.39%
2014-06-30 $0.15B $0.56B 31.42%
2014-03-31 $0.23B $0.48B 51.51%
2013-12-31 $0.23B $0.47B 60.47%
2013-09-30 $0.30B $0.44B 82.02%
2013-06-30 $0.29B $0.39B 83.66%
2013-03-31 $0.17B $0.22B 52.90%
2012-12-31 $0.16B $0.40B 49.61%
2012-09-30 $0.16B $0.36B 59.56%
2012-06-30 $0.17B $0.29B 77.83%
2012-03-31 $0.15B $0.24B 85.59%
2011-12-31 $0.18B $0.20B 139.96%
2011-09-30 $0.91B $0.15B 1143.57%
2011-06-30 $0.89B $0.10B -576.26%
2011-03-31 $0.91B $0.07B -238.59%
2010-12-31 $0.87B $-0.00B -141.78%
2010-09-30 $0.13B $-0.78B -15.72%
2010-06-30 $0.12B $-0.82B -13.38%
2010-03-31 $0.06B $-0.86B -6.86%
2009-12-31 $0.07B $-0.90B -6.95%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.044B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.532B 10.00
Quest Diagnostics (DGX) United States $14.447B 14.94
DaVita (DVA) United States $11.622B 15.81
Chemed (CHE) United States $9.137B 28.75
Elanco Animal Health (ELAN) United States $6.389B 14.53
Option Care Health (OPCH) United States $5.286B 20.69
RadNet (RDNT) United States $3.263B 95.30
Amedisys (AMED) United States $2.981B 21.27
LifeStance Health (LFST) United States $2.235B 0.00
Astrana Health (ASTH) United States $2.075B 26.17
Addus HomeCare (ADUS) United States $1.517B 23.26
U.S Physical Therapy (USPH) United States $1.506B 39.03
Pennant (PNTG) United States $0.626B 36.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.310B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.030B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00